Cardiothoracic surgeon Louis H. Stein, MD, PhD, the Surgical Director of the ECMO (Extracorporeal Membrane Oxygenation) and Director of Cardiovascular Research at Newark Beth Israel Medical Center, explains the difference between VV ECMO and VA ECMO and its role in acute respiratory distress, heart failure and cardiopulmonary support.
Learn more about the Newark Beth Israel Lung Transplant and Advanced Lung Failure program.
For more on the Newark Beth Israel Heart Transplant Program: rwjbh.org/nbihearttransplant.
Newark Beth Israel Medical Center, an RWJBarnabas Health facility, is a 665-bed quaternary care referral medical center that provides comprehensive health care for advanced lung, advanced heart failure and heart transplant. Newark Beth Israel is a Top Teaching Hospital and home to one of the nation's top 15 heart transplant centers, Newark Beth Israel’s Heart Transplant and Heart Failure Treatment Program, for heart-lung transplants, heart transplants and left ventricular assist devices (LVADs, VADs) implants; New Jersey's only Advanced Lung Disease and Lung Transplant Program for asthma, COPD, cystic fibrosis, interstitial lung disease, pulmonary hypertension, and advanced lung care (ECMO and bronchial thermoplasty) and a Structural Heart Disease and Valve Center for complex cardiac procedures, aortic diseases, aortic repair, including minimally invasive transcatheter aortic valve replacements (TAVRs), percutaneous coronary intervention (PCI), Mitral Clip valve repair and Watchman implants for afib.